# Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments

> **NCT04809311** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 156 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Oral antidiabetetic drugs
- **DRUG:** Basal insulin
- **DRUG:** Glucagon-like peptide-1 (GLP-1)

## Key facts

- **NCT ID:** NCT04809311
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-30
- **Primary completion:** 2025-01-07
- **Final completion:** 2025-01-07
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04809311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04809311, "Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04809311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*